Menu
Recruiting NCT06554119

Surgical Treatments of Tricuspid Valve Regurgitation After Cardiac Surgery

— Observational Tricuspid Valve Regurgitation; Complications, Longterm Outcome

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Huanlei Huang.
Who it may be relevant to
Registry conditions: Tricuspid Valve Regurgitation; Complications, Longterm Outcome. Basic parameters: from 16 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
China
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University

Overview

This study aims to present our center's experience in managing postoperative tricuspid valve regurgitation over the past 25years and to analyze the outcomes of these surgical treatments.

Interventions

  • Procedure Huanlei Huang
    tricuspid valve replacement or plasty

Primary outcome measures

  • death rate [Time frame: 1999-01 - 2025-01]
  • complications [Time frame: 1999-01 - 2025-01]
Secondary outcome measures (1)
  • redo of tricuspid valve [Time frame: 1999-01 - 2025-01]

Eligibility criteria

Inclusion Criteria:patients who underwent surgical treatment from 1999 to 2023 for tricuspid valve disease following cardiac surgery

Exclusion Criteria: age <16，severe tricuspid regurgitation secondary to primary pulmonary hypertension, and those with substantial missing case data.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Cohort

Study locations

China · 1 center
  • Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern M — Guangzhou

Identifiers

NCT: NCT06554119 · Guangdong Provincial PHosp

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗